Please use this identifier to cite or link to this item:
Title: In silico and in vitro validation of some benzimidazole derivatives as adenosine deaminase inhibitors
Authors: Arun, K G
Sharanya, C S
Abhithaj, J
Sadasivan, C
Keywords: Adenosine deaminase;Benzimidazole;Inhibition assay;Fluorescence spectroscopy;Molecular dynamics
Issue Date: Aug-2020
Publisher: NISCAIR-CSIR, India
Abstract: Benzimidazole nucleus considered as an important scaffold for developing drug candidates against a wide spectrum of diseases. Adenosine deaminase (ADA), an enzyme present in purine metabolic pathway, has a significant role in inflammatory and malignant diseases and hence it is considered as a major target for drug development. The present study investigates ADA inhibitory potential of selected benzimidazole derivatives by using in silico and in vitro methods. Molecular docking and dynamics simulations have been carried out to identify potential ADA activesite binders from benzimidazole derivatives. Compounds having strong binding affinities were selected for enzyme inhibition assays and fluorescent binding studies. The results showed that the pyridinyl and butyl derivatives of benzimidazole possess significant ADA inhibitory potential.The study proposes these compounds can be used as potent candidates for developing ADA inhibitor drugs.
Page(s): 1175-1182
ISSN: 0975-0983(Online); 0376-4699(Print)
Appears in Collections:IJC-B Vol.59B(08) [August 2020]

Files in This Item:
File Description SizeFormat 
IJCB 59B(8) 1175-1182.pdf701.51 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.